The connection between allergic rhinitis and bronchial asthma

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 1, 2007, Pages 13-18

  Corren, Jonathan ^a  

^a Allergy Research Foundation   (United States)

Author keywords

Allergic rhinitis; Asthma; Bronchial hyperresponsiveness; Nitric oxide

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; DECONGESTIVE AGENT; DESLORATADINE; FEXOFENADINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; METHACHOLINE; MONTELUKAST; NITRIC OXIDE; PSEUDOEPHEDRINE;

ALLERGIC RHINITIS; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG INDICATION; DRUG POTENTIATION; EARLY DIAGNOSIS; EMERGENCY WARD; HAY FEVER; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; LOWER RESPIRATORY TRACT; LUNG FUNCTION; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; REVIEW; RISK FACTOR;

ADRENAL CORTEX HORMONES; ASTHMA; BRONCHIAL HYPERREACTIVITY; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOTHERAPY; LEUKOTRIENE ANTAGONISTS; RESPIRATORY SYSTEM; RHINITIS, ALLERGIC, SEASONAL;

EID: 33845424938     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328010d0db     Document Type: Review

References (55)

1. Yawn BP, Yunginger JW, Wollan PC, et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on healthcare utilization. J Allergy Clin Immunol 1999; 103:54-59.
2. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998; 101:188-195.
3. Townley R, Ryo U, Kolotin B, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975; 56:429-437.
4. Ciprandi G, Cirillo I, Tosca MA, Vizzaccaro A. Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis. Respir Med 2004; 98:826-831.
5. Ciprandi G, Cirillo I, Tosca MA, Vizzaccaro A. Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis. Int Arch Allergy Immunol 2004; 133:14-18.
6. Witteman AM, Simsoedin DH, Jansen HM, Vanderzee JS. Differences in nonspecific bronchial responsiveness between patients with asthma and patients with rhinitis are not explained by type and degree of inhalant allergy. Int Arch Allergy Immunol 1997; 112:65-72.
7. Mete N, Siin A, Gulbahar O, Erdinc M, et al. The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2004; 93:193-199.
8. Bavbek S, Saryal S, Karabiyikoglu G, Misirligil Z. Pulmonary function parameters in patients with allergic rhinitis. J Investig Allergol Clin Immunol 2003; 13:252-258.
9. Djukanovic R, Lai CK, Wilson JW, et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics, and healthy controls. Eur Respir J 1992; 5:538-544.
10. Chakir J, Laviolette M, Turcotte H, et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000; 106:904-910.
11. Gutierrez V, Prieto L, Torres V, et al. Variability and sputum eosinophilia in allergic rhinitis. Ann Allergy Asthma Immunol 1998; 81:143-150.
12. Polosa R, Ciamarra I, Mangana G, et al. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000; 15:30-35.
13. Boulay ME, Boulet LP. Influence of natural exposure to pollens and domestic animals on airway reponsiveness and inflammation in sensitized nonasthmatic subjects. Int Arch Allergy Immunol 2002; 128:336-343.
14. Alvarez Puebla MJ, Castillo R, et al. Sputum eosinophilia and maximal airway narrowing in Dermatophagoides pteronyssinus allergic rhinitis patients: only rhinitis or rhinitis plus mild asthma? Chest 2002; 122:1560-1565.
15. Taylor DR, Pijnenburg MW, Smith AD, Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006; 61:817-827. Very up-to-date review that highlights the clinical utility of nitric oxide analysis, pointing out the strengths and pitfalls.
16. Prieto L, Gutierrez V, Uixera S, Bruno L. Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen. Clin Exp Allergy 2002; 32:1728-1733.
17. Cardinale F, de Benedictis FM, Muggeo V, et al. Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis. Pediatr Allergy Immunol 2005; 16:236-242. This paper assesses the association between markers of atopy and exhaled nitric oxide in patients with asthma and rhinitis.
18. Aronsson D, Tufvesson E, Bjermer L. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy 2005; 35:1457-1461. Excellent data demonstrating the differences in nitric oxide production between rhinitic patients and asthmatic patients.
19. Chakir J, Laviolette M, Boutet M, et al. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996; 75:735-744.
20. Rusconi F, Galassi C, Corbo GM, et al. Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group. Am J Respir Crit Care Med 1999; 160:1617-1622.
21. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104:301-304.
22. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994; 15:21-25.
23. Huovinen E, Kaprio J, Laitinen LA, Koskenvuo M. Incidence and prevalence of asthma among adult Finnish men and women of the Finnish Twin Cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest 1999; 115:928-936.
24. Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000; 162:920-924.
25. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109:419-425.
26. Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987; 91:671-674.
27. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003; 111:1171-1183.
28. Huse DM, Harte SC, Russel MW, et al. Allergic rhinitis may worsen asthma symptoms in children: the International Asthma Outcomes Registry [abstract]. Am J Respir Crit Care Med 1996; 153:A860.
29. Halpern MT, Schmier JK, Richner R, et al. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma 2004; 41:117-126.
30. Kanani A, Broder I, Greene J, Tarlo SM. Correlation between nasal symptoms and asthma severity in patients with atopic and nonatopic asthma. Ann Allergy Asthma Immunol 2005; 94:341-347. These authors attempt to assess the severity of asthma, comparing rhinitic patients with nonrhinitic patients; however, some of the subgroup sample sizes used in this study were small.
31. Schumacher MJ, Cota KA, Taussig LM. Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma. J Allergy Clin Immunol 1986; 78:30-35.
32. Aubier M, Neukirch C, Peiffer C, Melac M. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma. Allergy 2001; 56:35-42.
33. Bonay M, Neukirch C, Grandsaigne M, et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy 2006; 61:111-118. Important laboratory study that helps confirm the effect of nasal allergen provocation on lower airway inflammation.
34. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469-476.
35. Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051-2057.
36. Assanasen P, Baroody FM, Naureckas E, et al. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med 2001; 164:1640-1646.
37. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children - a 14-year study. Pediatrics 1968; 42:793-802.
38. Niggemann B, Jacobsen L, Dreborg S. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 2006; 61:855-859. Landmark study demonstrating that allergy immunotherapy had a protective effect on the development of asthma; this paper presents the data after 5 years of follow-up.
39. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114:851-857.
40. Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res 2005; 6:153-160. Retrospective study revealing that immunotherapy also protects against the development of asthma in adults.
41. Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone, nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987; 62:125-134.
42. Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005; 60:875-881. Largest study to date examining effects of intranasal corticosteroids upon asthma symptoms, which revealed no beneficial effects.
43. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90:250-256.
44. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91:979-1001.
45. Foresi A, Pelucchi A, Gherson G, et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996; 98:274-282.
46. Henriksen JW, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984; 130:1014-1018.
47. Corren J, Manning BE, Thompson SF, et al. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004; 113:415-419.
48. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995; 95:923-932.
49. Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003; 130:307-313.
50. Lee DK, Jackson CM, Haggart K, Lipworth BJ. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. Chest 2004; 125:1372-1377.
51. Corren J, Harris AG, Aaronson D. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997; 100:781-788.
52. Philip G, Malmstrom K, Hampel FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002; 32:1020-1028.
53. Patel P, Philip G, Yang W, et al. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95:551-557. Analysis of large-sample, phase 3 study data showing that montelukast is effective in perennial allergic rhinitis.
54. Mucha SM, deTineo M, Naclerio RM, Baroody FM. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg 2006; 132:164-172. Small trial demonstrating that montelukast and pseudoephedrine have similar efficacies in treating symptoms of allergic rhinitis.
55. Martin BG, Andrews CP, van Bavel JH. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol 2006; 96:851-857. Large, multicentre trial demonstrating superior symptom control of seasonal allergic rhinitis with intranasal fluticasone compared with montelukast.